Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

VIE/MARI stock hub

VIE/MARI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

VIE/MARIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

21.8M

Vienna Stock Exchange

Market data

Price

Recent price action with selectable time range.

VIE/MARIVIE/MARI

—

Loading chart…

In the news

Latest news · VIE/MARI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E7.3

P25 n/aP50 n/aP75 n/a

Trailing P/E1.1

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-7.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All VIE/MARI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

172

Groups with data

Currency

EUR

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Austria
Country code	AT
Employees	32
Employees Change	-15%
Employees Change Percent	-31.91
Enterprise value	EUR 32.4M
Exchange	Vienna Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	ATMARINOMED6
Last refreshed	2026-05-10
Market cap	EUR 21.8M
Price	EUR 10.9
Price currency	EUR
Rev Per Employee	248,751.84x
Sector	Healthcare
Sic	2834
Symbol	vie/MARI
Website	https://www.marinomed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	82.69%
EV Earnings	1.8x
EV/Sales	4.07x
Forward P/E	7.32x
P/B ratio	-3.09x
P/E ratio	1.11x
P/S ratio	2.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3.32%
EBITDA Margin	0.6%
Gross margin	82.15%
Gross Profit	EUR 6.5M
Gross Profit Growth	537.42%
Gross Profit Growth Q	18.7%
Gross Profit Growth3 Y	40.68%
Net Income	EUR 18M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	227.69%
Profit Margin	226.36%
Profit Per Employee	EUR 563,071
Profitable Years	1
ROA	-2.33
Roa5y	-19.48
ROCE	-147.9
ROIC	-7.36
Roic5y	-74.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-11.79%
Cagr3y	-32.07%
Cagr5y	-38.47%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	66.08x
Revenue Growth Q	-76.89x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	-12.16x
Revenue Growth5 Y	-0.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.13
Assets	EUR 6M
Cash	EUR 951,780
Current Assets	EUR 1.4M
Current Liabilities	EUR 5.8M
Debt	EUR 11.6M
Debt EBITDA	EUR 241
Equity	EUR -7M
Interest Coverage	-0.49
Liabilities	EUR 13M
Long Term Assets	EUR 4.5M
Long Term Liabilities	EUR 7.2M
Net Cash	EUR -10.6M
Net Cash By Market Cap	EUR -48.69
Net Debt EBITDA	EUR 221
Tangible Book Value	EUR -7.1M
Tangible Book Value Per Share	EUR -3.84
WACC	3.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.25
Inventory Turnover	5.27
Net Working Capital	EUR 42,515
Quick ratio	0.22
Working Capital	EUR -4.3M
Working Capital Turnover	EUR -0.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-11.79%
200-day SMA	18.43
3Y total return	-68.66%
50-day SMA	14.84
50-day SMA vs 200-day SMA	50under200
5Y total return	-91.18%
All Time High	147
All Time High Change	-92.59%
All Time High Date	2021-02-19
All Time Low	2
All Time Low Change	445%
All Time Low Date	2024-08-15
ATR	0.89
Beta	-0.16
Beta1y	0.04
Beta2y	0.01
Ch YTD	-42.93
High	11
High52	21
High52 Date	2025-10-31
High52ch	-48.1%
Low	10.2
Low52	8.6
Low52 Date	2026-05-05
Low52ch	26.74%
Ma50ch	-26.57%
Price vs 200-day SMA	-40.85%
RSI	32.71
RSI Monthly	32.22
RSI Weekly	19.68
Sharpe ratio	-0.36x
Sortino ratio	-0.36
Total Return	-3.46%
Tr YTD	-42.73
Tr1m	-22.7%
Tr1w	-5.22%
Tr3m	-37.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -263,877
Operating margin	-3.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,438,531%
Shares Insiders	28.04%
Shares Institutions	18.45%
Shares Out	1,998,979
Shares Qo Q	0%
Shares Yo Y	3.46%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	6,039.85x
Bv Per Share	-3.83
Ch1m	-22.7
Ch1w	-5.22
Ch1y	-12.1
Ch3m	-38.07
Ch3y	-68.77
Ch5y	-91.21
Ch6m	-45.5
Change	-1.8%
Change From Open	-0.91
Close	11.1
Days Gap	-0.9
Depreciation Amortization	311,894
Dollar Volume	38,444.3
Earnings Date	2026-04-22
EBIT	EUR -263,877
EBITDA	EUR 48,017
EPS	EUR 9.79
F Score	4
Financing CF	300,000
Fiscal Year End	December
Founded	2,006
Income Tax	EUR 106,098
Is Primary Listing	1
Last Earnings Date	2026-04-22
Last Report Date	2025-12-31
Ma150	17.9
Ma150ch	-39.1%
Ma20	12.86
Ma20ch	-15.21%
Net CF	-700,000
Next Earnings Date	2026-09-16
Open	11
Position In Range	87.5
Ppne	4,506,114
Price Date	2026-05-08
Price EBITDA	EUR 454
Relative Volume	0.57x
Revenue	7,960,059x
Tax By Revenue	1.33x
Tax Rate	0.59%
Tr6m	-45.31%
Volume	3,527
Z Score	-10.69

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does VIE/MARI pay a dividend?

Capital-return profile for this ticker.

Performance

VIE/MARI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns VIE/MARI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.5%

Share of float held by funds and institutions

Insider ownership

+28.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.5%

Negative means the company is buying back shares.

Technical

VIE/MARI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.7

Neutral momentum band

Price vs 200-day MA

-40.9%

50/200-day relationship not available

Beta (5Y)

-0.16

Less volatile than the market

Sharpe ratio

-0.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About VIE/MARI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current vie/MARI stock rating?

vie/MARI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full vie/MARI analysis?

The full report lives at /stocks/vie/MARI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for vie/MARI?

The latest report frames vie/MARI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the vie/MARI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.